Biotech · Private company
Oncolys BioPharma Inc
Track this companyFree. Adds Oncolys BioPharma Inc to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- OBP-801Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric AdenocarcinomaPHASE2 · RECRUITING · started Apr 25, 2024ClinicalTrials.gov NCT06340711 · fetched Nov 12, 2026
- Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive DiseasePHASE2 · TERMINATED · started May 3, 2021ClinicalTrials.gov NCT04685499 · fetched Nov 12, 2026
- Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric AdenocarcinomaPHASE2 · COMPLETED · started May 9, 2019ClinicalTrials.gov NCT03921021 · fetched Nov 12, 2026
- A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid TumorsPHASE1 · UNKNOWN · started Mar 1, 2015ClinicalTrials.gov NCT02414516 · fetched Nov 12, 2026